Interim statement on heterologous priming for COVID-19 vaccines

WHO with support of the Strategic Advisory Group of Experts (SAGE) on Immunization and its COVID-19 Vaccines Working Group has reviewed the emerging and available evidence and has issues interim guidance on the use of heterologous priming schedules (also known as mix and match schedules).